{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:10Z","timestamp":1759336330268,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00467-021-05080-1","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T04:02:33Z","timestamp":1622001753000},"page":"3741-3747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Fatemeh","family":"Hamedi-Kalajahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meysam","family":"Zarezadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed Yousef","family":"Mojtahedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakineh","family":"Shabbidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariyoosh","family":"Fahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Imani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"5080_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713\u2013735. https:\/\/doi.org\/10.1053\/j.ajkd.2014.01.416","journal-title":"Am J Kidney Dis"},{"key":"5080_CR2","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS et al (2016) Global prevalence of chronic kidney disease\u2013a systematic review and meta-analysis. PLoS One 11:e0158765","journal-title":"PLoS One"},{"key":"5080_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, Van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363\u2013373 Erratum in 27:507","journal-title":"Pediatr Nephrol"},{"key":"5080_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583\u2013591. https:\/\/doi.org\/10.1093\/ckj\/sfw047","journal-title":"Clin Kidney J"},{"key":"5080_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneph.2009.10","volume":"5","author":"MR Lilien","year":"2009","unstructured":"Lilien MR, Groothoff JW (2009) Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 5:229","journal-title":"Nat Rev Nephrol"},{"key":"5080_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.ajkd.2012.07.018","volume":"60","author":"CJ Wong","year":"2012","unstructured":"Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60:1002\u20131011. https:\/\/doi.org\/10.1053\/j.ajkd.2012.07.018","journal-title":"Am J Kidney Dis"},{"key":"5080_CR7","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00467-015-3075-9","volume":"30","author":"M Khurana","year":"2015","unstructured":"Khurana M, Silverstein DM (2015) Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 30:2073\u20132084","journal-title":"Pediatr Nephrol"},{"key":"5080_CR8","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M (2016) Carnitine transport and fatty acid oxidation. Biochim Biophys Acta 1863:2422\u20132435. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023","journal-title":"Biochim Biophys Acta"},{"key":"5080_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5527\/wjn.v5.i3.274","volume":"5","author":"J Tu","year":"2016","unstructured":"Tu J, Cheung WW, Mak RH (2016) Inflammation and nutrition in children with chronic kidney disease. World J Nephrol 5:274. https:\/\/doi.org\/10.5527\/wjn.v5.i3.274","journal-title":"World J Nephrol"},{"key":"5080_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00467-006-0408-8","volume":"22","author":"E Verrina","year":"2007","unstructured":"Verrina E, Caruso U, Calevo MG, Emma F, Sorino P, De Palo T et al (2007) Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis. Pediatr Nephrol 22:727\u2013733","journal-title":"Pediatr Nephrol"},{"key":"5080_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1525-139X.2006.00180.x","volume":"19","author":"SS Hedayati","year":"2006","unstructured":"Hedayati SS (2006) Dialysis-related carnitine disorder. Semin Dial 19:323\u2013328","journal-title":"Semin Dial"},{"key":"5080_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5144\/0256-4947.2003.270","volume":"23","author":"TH El-Metwally","year":"2003","unstructured":"El-Metwally TH, Hamed EA, Ahmad AR, Mohamed NA (2003) Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: effects of L-carnitine supplementation. Ann Saudi Med 23:270\u2013277","journal-title":"Ann Saudi Med"},{"key":"5080_CR13","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00467-003-1302-2","volume":"18","author":"C Ko\u015fan","year":"2003","unstructured":"Ko\u015fan C, Sever L, Ar\u0131soy N, \u00c7al\u0131\u015fkan S, Kasap\u00e7opur \u00d6 (2003) Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:1184\u20131188","journal-title":"Pediatr Nephrol"},{"key":"5080_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000168064","volume":"10","author":"BA Warady","year":"1990","unstructured":"Warady BA, Borum P, Stall C, Millspaugh J, Taggart E, Lum G (1990) Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 10:109\u2013114. https:\/\/doi.org\/10.1159\/000168064","journal-title":"Am J Nephrol"},{"key":"5080_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1542-4758.2010.00476.x","volume":"14","author":"A Shakeri","year":"2010","unstructured":"Shakeri A, Tabibi H, Hedayati M (2010) Effects of l-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial Int 14:498\u2013504. https:\/\/doi.org\/10.1111\/j.1542-4758.2010.00476.x","journal-title":"Hemodial Int"},{"key":"5080_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1442-200X.2002.01498.x","volume":"44","author":"S Mir","year":"2002","unstructured":"Mir S, Kantar M, Yalaz M, Keskinoglu A, Coker IS, Huseyinov A (2002) Effect of hemodialysis on carnitine levels in children with chronic renal failure. Pediatr Int 44:70\u201373. https:\/\/doi.org\/10.1046\/j.1442-200X.2002.01498.x","journal-title":"Pediatr Int"},{"key":"5080_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1442-200X.1998.tb01397.x","volume":"40","author":"R Topalo\u011flu","year":"1998","unstructured":"Topalo\u011flu R, Celiker A, Saat\u00e7i U, Kilin\u00e7 K, Bakkalo\u011flu A, Be\u015fba\u015f N, Seza\u00f6zen TK (1998) Effect of carnitine supplementation on cardiac function in hemodialyzed children. Pediatr Int 40:26\u201329. https:\/\/doi.org\/10.1111\/j.1442-200X.1998.tb01397.x","journal-title":"Pediatr Int"},{"key":"5080_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/014860710603000110","volume":"30","author":"AL Steiber","year":"2006","unstructured":"Steiber AL, Davis AT, Spry L, Strong J, Buss ML, Ratkiewicz MM et al (2006) Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients. J Parenter Enter Nutr 30:10\u201315. https:\/\/doi.org\/10.1177\/014860710603000110","journal-title":"J Parenter Enter Nutr"},{"key":"5080_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08860220903288534","volume":"32","author":"HP Patel","year":"2010","unstructured":"Patel HP (2010) Early origins of cardiovascular disease in pediatric chronic kidney disease. Ren Fail 32:1\u20139","journal-title":"Ren Fail"},{"key":"5080_CR20","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","volume":"13","author":"JC Longenecker","year":"2002","unstructured":"Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A et al (2002) Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 13:1918\u20131927. https:\/\/doi.org\/10.1097\/01.ASN.0000019641.41496.1E","journal-title":"J Am Soc Nephrol"},{"key":"5080_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/ki.2010.311","volume":"78","author":"JM Saland","year":"2010","unstructured":"Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC et al (2010) Dyslipidemia in children with chronic kidney disease. Kidney Int 78:1154\u20131163. https:\/\/doi.org\/10.1038\/ki.2010.311","journal-title":"Kidney Int"},{"key":"5080_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/ndt\/14.6.1462","volume":"14","author":"ND Vaziri","year":"1999","unstructured":"Vaziri ND, Deng G, Liang K (1999) Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Nephrol Dial Transplant 14:1462\u20131466. https:\/\/doi.org\/10.1093\/ndt\/14.6.1462","journal-title":"Nephrol Dial Transplant"},{"key":"5080_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","volume":"10","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND, Moradi H (2006) Mechanisms of dyslipidemia of chronic renal failure. Hemodial Int 10:1\u20137. https:\/\/doi.org\/10.1111\/j.1542-4758.2006.01168.x","journal-title":"Hemodial Int"},{"key":"5080_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S0899-9007(01)00601-3","volume":"17","author":"Y Feng","year":"2001","unstructured":"Feng Y, Guo C, Wei J, Yang J, Ge Y, Gao L (2001) Necessity of carnitine supplementation in semistarved rats fed a high-fat diet. Nutrition 17:628\u2013631. https:\/\/doi.org\/10.1016\/S0899-9007(01)00601-3","journal-title":"Nutrition"},{"key":"5080_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1194\/jlr.M300425-JLR200","volume":"45","author":"Y Tanaka","year":"2004","unstructured":"Tanaka Y, Sasaki R, Fukui F, Waki H, Kawabata T, Okazaki M et al (2004) Acetyl-L-carnitine supplementation restores decreased tissue carnitine levels and impaired lipid metabolism in aged rats. J Lipid Res 45:729\u2013735. https:\/\/doi.org\/10.1194\/jlr.M300425-JLR200","journal-title":"J Lipid Res"},{"key":"5080_CR26","doi-asserted-by":"publisher","first-page":"A25","DOI":"10.1016\/S0002-8223(95)00436-X","volume":"95","author":"L Zarny","year":"1995","unstructured":"Zarny L, Bernstein L (1995) Serum cholesterol: an indicator of malnutrition. J Am Diet Assoc 95:A25. https:\/\/doi.org\/10.1016\/S0002-8223(95)00436-X","journal-title":"J Am Diet Assoc"},{"key":"5080_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2215\/CJN.09830915","volume":"11","author":"Y Sato","year":"2016","unstructured":"Sato Y, Fujimoto S, Toida T, Nakagawa H, Yamashita Y, Iwakiri T et al (2016) Apoprotein B\/apoprotein A-1 ratio and mortality among prevalent dialysis patients. Clin J Am Soc Nephrol 11:840\u2013846. https:\/\/doi.org\/10.2215\/CJN.09830915","journal-title":"Clin J Am Soc Nephrol"},{"key":"5080_CR28","first-page":"185","volume":"1","author":"D Kirmizis","year":"2007","unstructured":"Kirmizis D, Koutoupa E, Tsiandoulas A, Valtopoulou A, Niavis G, Markou P, Barboutis K (2007) Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis. Biomark Insights 1:185\u2013192","journal-title":"Biomark Insights"},{"key":"5080_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11745-000-0566-2","volume":"35","author":"M Diaz","year":"2000","unstructured":"Diaz M, Lopez F, Hernandez F, Urbina JA (2000) l-Carnitine effects on chemical composition of plasma lipoproteins of rabbits fed with normal and high cholesterol diets. Lipids 35:627\u2013632. https:\/\/doi.org\/10.1007\/s11745-000-0566-2","journal-title":"Lipids"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05080-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T06:19:36Z","timestamp":1633673976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05080-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5080"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05080-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Tehran Medical University Research Ethical Committee (IR.TUMS.VCR.REC.1397.1067).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We declare that the study was performed according to the international, national, and institutional rules considering animal experiments, clinical studies, human and animal rights, and biodiversity rights.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"All participants in this study were informed about the objectives of the study and the side effects of the dietary supplement used in the intervention. The informed consent form for this research was approved and signed by the participants or their legal guardians at the beginning of the study. This publication has the right to request the relevant documents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}